Intrinsiqq
Cellectar Biosciences, Inc. logo

Cellectar Biosciences, Inc. Insider Trading

CLRB

Compare
Last 12 months

Insiders bought 50K and sold $733 on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director John Neis sold $733 on Dec 12, 2025, 95% of their stake, outside a plan.

Net open-market
+49K
2 buys · 1 sale
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
2 / 1
executives and directors
Last open-market buy
May 2026
May 7, 2026

Get an email when CLRB's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • May 7
    Jarrod Longcor
    Chief Operating Officer · bought 8,680 at $2.88
    25K
    74% of stake
  • May 7
    James V Caruso
    Chief Executive Officer · bought 8,680 at $2.88
    25K
    75% of stake
  • Dec 12, 2025No plan
    John Neis
    Director · sold 198 at $3.70
    $733
    95% of stake
  • Jul 2, 2025
    James V Caruso
    Chief Executive Officer · bought 10,000 at $4.99
    50K
    611% of stake
  • Jul 2, 2025
    Jarrod Longcor
    Chief Operating Officer · bought 10,000 at $4.99
    50K
    361% of stake
  • Jul 2, 2025
    Chad J Kolean
    Chief Financial Officer · bought 5,000 at $4.99
    25K
    353% of stake
  • Jan 10, 2025
    Jarrod Longcor
    Chief Operating Officer · bought 30,000 at $0.28
    8K
    56% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CLRB, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with CLRB

CompareIntrinsic value
LQDALiquidia Corporation
$54.43-3.88%63
PCRXPacira BioSciences Inc.
$36.48+0.00%61
SRPTSarepta Therapeutics Inc.
$13.33-5.93%58
ETONEton Pharmaceuticals Inc.
$60.85-0.83%75
ZBIOZenas BioPharma, Inc.
$23.85-4.75%10
AGIOAgios Pharmaceuticals Inc.
$27.60-4.03%40
PBHPrestige Consumer Healthcare Inc.
$49.63+0.06%48
ZYMEZymeworks Inc.
$26.14-2.68%10

Spot a number that looks wrong? Check it in CLRB's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing CLRB

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.